Crescent Biopharma (CBIO) Other Non Operating Income (2013 - 2026)
Crescent Biopharma (CBIO) posted quarterly Other Non Operating Income of $1.5 million for Q2 2026, up 300.92% year-over-year from $380873.0 in Q2 2025, and up 5.6% quarter-over-quarter from $1.4 million in Q1 2026.
Crescent Biopharma (CBIO) Other Non Operating Income (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has reported Other Non Operating Income for 8 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non Operating Income rose 300.92% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $3.5 million (up 572.02% YoY), while the FY2017 annual figure was $651212.0, up 528.3% from the prior year.
- Other Non Operating Income climbed to $1.5 million in Q2 2026 per CBIO's latest filing, from $1.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.5 million in Q2 2026 and bottomed at -$924000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Crescent Biopharma | 1.10 Bn | 933.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | -760,000.00 |
| Mar 31, 2025 | -924,000.00 |
| Sep 30, 2018 | 944,409.00 |
| Jun 30, 2018 | 870,139.00 |
| Mar 31, 2018 | 363,704.00 |
| Dec 31, 2017 | 278,004.00 |
| Sep 30, 2017 | 231,634.00 |
| Jun 30, 2017 | 102,079.00 |
| Mar 31, 2017 | 39,495.00 |
| Dec 31, 2016 | 29,673.00 |
| Sep 30, 2016 | 32,063.00 |
| Jun 30, 2016 | 21,813.00 |
| Mar 31, 2016 | 20,097.00 |
| Dec 31, 2015 | 5,823.00 |
| Sep 30, 2015 | 3,302.00 |
| Jun 30, 2015 | 2,638.00 |
| Mar 31, 2015 | 3,564.00 |